Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Featured Company (BOS Basel 2024)

Axplora
Axplora, created from the merger of Farmabios, Novasep and PharmaZell, is a leading API manufacturing partner to the world’s leading pharmaceutical and biotechnology companies, delivering top quality active ingredients on time and at scale, to the highest industry standards. Axplora is dedicated to...
View profile

Featured Speaker (BOS Basel 2024)

In-house Manufacture or External Sourcing of Gene Editing Reagents to Support the Growing Cell and Gene Therapy Business

Dr Ulrich Rümenapp, Senior Program Lead, Bayer AG

ABSTRACT: Beyond small molecule drugs and classical biopharmaceuticals like antibodies, cell and gene therapies are becoming more and more important to treat patients with severe diseases. Genome editing holds a great promise for cell-based therapies. Reliable manufacture and supply of the reagents used for gene editing - in the necessary quality - is essential. Depending on the application, gene editing reagents (GERs) may be starting materials or drug substances to be made following GMP principles or under full GMP. For development, clinical and commercial manufacture, companies need to decide between... Click here to Read More